Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,623,948
-
Share change
-
+54,606
-
Total reported value
-
$188,308,375
-
Put/Call ratio
-
92%
-
Price per share
-
$10.68
-
Number of holders
-
88
-
Value change
-
+$584,108
-
Number of buys
-
2
Institutional Holders of ENDOCYTE INC - COM (ECYT) as of Q4 2013
As of 31 Dec 2013,
ENDOCYTE INC - COM (ECYT) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,623,948 shares.
The largest 10 holders included
FMR LLC, BB Biotech AG, BlackRock Fund Advisors, PINNACLE ASSOCIATES LTD, VANGUARD GROUP INC, MARXE AUSTIN W & GREENHOUSE DAVID M, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, RS INVESTMENT MANAGEMENT CO LLC, State Street Corp, and TANG CAPITAL MANAGEMENT LLC.
This page lists
88
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.